Clinical Lipidology

0.4(top 100%)

impact factor

496(top 50%)

papers

4.4K(top 20%)

citations

33(top 20%)

h-index

0.4(top 100%)

impact factor

564

all documents

4.6K

doc citations

47(top 20%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Apolipoproteins in the brain: implications for neurological and psychiatric disorders	Clinical Lipidology	2010	157
2	Perivascular adipose tissue and vascular disease	Clinical Lipidology	2011	97
3	Thromboxane and the thromboxane receptor in cardiovascular disease	Clinical Lipidology	2010	94
4	Mechanisms and clinical implications of hepatocyte lipoapoptosis	Clinical Lipidology	2010	89
5	Maternal lipid metabolism during normal pregnancy and its implications to fetal development	Clinical Lipidology	2010	78
6	The juvenile Batten disease protein, CLN3, and its role in regulating anterograde and retrograde post-Golgi trafficking	Clinical Lipidology	2012	74
7	Regulation of microsomal triglyceride transfer protein	Clinical Lipidology	2011	71
8	Lipid oxidation by hypochlorous acid: chlorinated lipids in atherosclerosis and myocardial ischemia	Clinical Lipidology	2010	65
9	Pitavastatin compared with atorvastatin in primary hypercholesterolemia or combined dyslipidemia	Clinical Lipidology	2009	59
10	Activation of lecithin: cholesterol acyltransferase by HDL ApoA-I central helices	Clinical Lipidology	2009	58
11	Essential fatty acids enhance free radical generation and lipid peroxidation toinduce apoptosis of tumor cells	Clinical Lipidology	2011	54
12	The ACCORD-Lipid study: implications for treatment of dyslipidemia in Type 2 diabetes mellitus	Clinical Lipidology	2011	52
13	Therapeutic potential of cyclodextrins in the treatment of Niemann–Pick type C disease	Clinical Lipidology	2012	52
14	Variations in lipid levels according to menstrual cycle phase: clinical implications	Clinical Lipidology	2011	50
15	Lysophosphatidic acid effects on atherosclerosis and thrombosis	Clinical Lipidology	2011	49
16	Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer’s disease?	Clinical Lipidology	2012	47
17	Mammalian diseases of phosphatidylinositol transfer proteins and their homologs	Clinical Lipidology	2010	46
18	Lipoproteins and lipoprotein metabolism in periodontal disease	Clinical Lipidology	2010	43
19	Niemann–Pick type C pathogenesis and treatment: from statins to sugars	Clinical Lipidology	2010	43
20	Formation of milk lipids: a molecular perspective	Clinical Lipidology	2009	42
21	Stable isotope-labeled tracers for the investigation of fatty acid and triglyceride metabolism in humansin vivo	Clinical Lipidology	2009	39
22	Role of different dietary saturated fatty acids for cardiometabolic risk	Clinical Lipidology	2011	39
23	Research advances with regards to clinical outcome and potential mechanisms of the cholesterol-lowering effects of probiotics	Clinical Lipidology	2012	39
24	A new model system swims into focus: using the zebrafish to visualize intestinal lipid metabolism in vivo	Clinical Lipidology	2009	38
25	Metabolic and cardiovascular effects of berberine: from preclinical evidences to clinical trial results	Clinical Lipidology	2009	38
26	Role of preadipocyte factor I in adipocyte differentiation	Clinical Lipidology	2010	38
27	The mutual interplay of lipid metabolism and the cells of the immune system in relation to atherosclerosis	Clinical Lipidology	2014	38
28	HDL as a contrast agent for medical imaging	Clinical Lipidology	2009	37
29	Lysosomes, cholesterol and atherosclerosis	Clinical Lipidology	2010	37
30	Pathophysiology of diabetic dyslipidemia:implications for atherogenesis and treatment	Clinical Lipidology	2011	37
31	Mechanisms of oxysterol-induced disease: insights from the biliary system	Clinical Lipidology	2012	36
32	Lipid signals and insulin resistance	Clinical Lipidology	2013	36
33	Examining the role of lipid mediators in diabetic retinopathy	Clinical Lipidology	2012	35
34	The interaction between metabolism, cancer and cardiovascular disease, connected by 27-hydroxycholesterol	Clinical Lipidology	2014	35
35	Adipogenic potential of skeletal muscle satellite cells	Clinical Lipidology	2009	33
36	Update on the efficacy and safety of combination ezetimibe plus statin therapy	Clinical Lipidology	2010	33
37	Phytotherapy for diabetic dyslipidemia: evidence from clinical trials	Clinical Lipidology	2013	33
38	Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress	Clinical Lipidology	2009	31
39	Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease	Clinical Lipidology	2011	30
40	Plant sterols: functional lipids in immune function and inflammation?	Clinical Lipidology	2009	29
41	Caveolae and lipid trafficking in adipocytes	Clinical Lipidology	2011	29
42	Lipoprotein apheresis: an update	Clinical Lipidology	2013	29
43	From risk factor assessment to cardiovascular disease risk and mortality modification: the first 40 years of the Brisighella Heart Study	Clinical Lipidology	2011	28
44	Management of dyslipidemia in HIV-infected patients	Clinical Lipidology	2011	28
45	Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to diabetes mellitus and other diseases: part II	Clinical Lipidology	2013	28
46	Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis	Clinical Lipidology	2013	27
47	Hepatobiliary transport in health and disease	Clinical Lipidology	2012	26
48	Cancer biomarkers and mass spectrometry-based analyses of phospholipids in body fluids	Clinical Lipidology	2013	25
49	Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to cancer: part I	Clinical Lipidology	2013	24
50	The effects of liraglutide on glucose, inflammatorymarkersandlipoprotein metabolism: current knowledge and future perspective	Clinical Lipidology	2013	24

Scientometrics

Overviews

Citing Bodies

Clinical Lipidology

Top Articles